Clinical trial design optimisation and dose rationale for the treatment of Buruli Ulcer antibiotic combination therapy

被引:0
|
作者
D'Agate, Salvatore [1 ]
Garcia Barrios, Noelia [1 ]
Millan Placer, Ana Cristina [2 ]
Lucia Quintana, Ainhoa [2 ]
Ramon Garcia, Santiago [3 ]
Della Pasqua, Oscar [4 ]
机构
[1] UCL, London, England
[2] Univ Zaragoza, Zaragoza, Spain
[3] Fdn ARAID, Zaragoza, Spain
[4] GlaxoSmithKline, Munich, Germany
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OC016
引用
收藏
页码:4882 / 4882
页数:1
相关论文
共 50 条
  • [21] Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy
    Klis, S.
    Kingma, R. A.
    Tuah, W.
    van der Werf, T. S.
    Stienstra, Y.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2016, 21 (09) : 1191 - 1196
  • [22] The ARREST Pneumonia Clinical Trial Rationale and Design
    Levitt, Joseph E.
    Festic, Emir
    Desai, Manisha
    Hedlin, Haley
    Mahaffey, Kenneth W.
    Rogers, Angela J.
    Gajic, Ognjen
    Matthay, Michael A.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (04) : 698 - 708
  • [23] Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design
    Madan, Ritu
    Celi, Francesco S.
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [24] Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening
    Pilar Arenaz-Callao, Maria
    Gonzalez del Rio, Ruben
    Lucia Quintana, Ainhoa
    Thompson, Charles J.
    Mendoza-Losana, Alfonso
    Ramon-Garcia, Santiago
    PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (01):
  • [25] Multimodal treatment concepts of local radiation therapy with immunotherapy. Rationale for combination therapy and possible clinical treatment strategies
    Eckert, Franziska
    UROLOGIE, 2022, 61 (12): : 1324 - 1331
  • [26] Treatment Rationale and Study Design for the TAKUMI Trial
    Tanaka, K.
    Asahina, H.
    Kishimoto, J.
    Sugio, K.
    Nakanishi, Y.
    Oizumi, S.
    Okamoto, I.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2286 - S2286
  • [27] Rationale, design, and baseline data for the Avonex Combination Trial (ACT)
    Cohen, J
    Calabresi, P
    Edwards, K
    Eickenhorst, T
    Felton, W
    Fisher, E
    Fox, R
    Goodman, A
    Hara-Cleaver, C
    Hutton, G
    Imrey, P
    Mandell, B
    Scott, TF
    Zhang, H
    NEUROLOGY, 2006, 66 (05) : A32 - A33
  • [28] Rationale for combination therapy with statin drugs in the treatment of dyslipidemia
    Ansell B.J.
    Current Atherosclerosis Reports, 2005, 7 (1) : 29 - 33
  • [29] Efficacy of nutritional support in combination with standard Buruli ulcer treatment: A case study in Cote d'Ivoire
    Koffi, Yao Didier
    Koffi, Paul Aboa
    Ehouman, Evans
    Kouadio, Saint-Pierre
    Kaloga, Mamadou
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2024, 37
  • [30] Rationale for fixed-dose combination therapy for the prevention of cardiovascular disease
    Borghi, Claudio
    JOURNAL OF HYPERTENSION, 2006, 24 : 417 - 417